Literature DB >> 26408063

Clinical Outcome Measures in Chiari I Malformation.

Chester K Yarbrough1, Jacob K Greenberg2, Tae Sung Park3.   

Abstract

Chiari malformation type 1 (CM-I) is a common and often debilitating neurologic disease. Reliable evaluation of treatments has been hampered by inconsistent use of clinical outcome measures. A variety of outcome measurement tools are available, although few have been validated in CM-I. The recent development of the Chicago Chiari Outcome Scale and the Chiari Symptom Profile provides CM-I-specific instruments to measure outcomes in adults and children, although validation and refinement may be necessary.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chiari malformation type 1; Clinical research; Outcome instruments; Outcome methods; Quality of life; Treatment outcome

Mesh:

Year:  2015        PMID: 26408063     DOI: 10.1016/j.nec.2015.06.008

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN: 1042-3680            Impact factor:   2.509


  5 in total

1.  Management opinions from different centers (Rio de Janeiro).

Authors:  José Francisco M Salomão; Tatiana Protzenko Cervante; Antonio Rosa Bellas
Journal:  Childs Nerv Syst       Date:  2019-05-15       Impact factor: 1.475

2.  [Effects of age and gender on posterior cranial fossa linear volume and cerebellar tonsil position in normal populations].

Authors:  Sheng Yang; Chao Tang; Haibo Li; Dejun Zhong
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-09-15

Review 3.  Precise Management of Chiari Malformation with Type I.

Authors:  Fuyou Guo; Mehmet Turgut
Journal:  Front Surg       Date:  2022-03-28

4.  Multidimensional, patient-reported outcome after posterior fossa decompression in 79 patients with Chiari malformation type I.

Authors:  Jan De Vlieger; Joost Dejaegher; Frank Van Calenbergh
Journal:  Surg Neurol Int       Date:  2019-12-13

5.  Emergency Department Visits Following Suboccipital Decompression for Adult Chiari Malformation Type I.

Authors:  James Feghali; Elizabeth Marinaro; Yangyiran Xie; Yuxi Chen; Sean Li; Judy Huang
Journal:  World Neurosurg       Date:  2020-09-18       Impact factor: 2.104

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.